1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Patient demographics, tumor secretory status and tumor size in 390 patients with pituitary macroadenomas
Clival Invasion Sex Age Pathologic Subtype Volume Male Female χ2, P Value Mean (yr) 2 Independent-Samples t Test Null-Cell Secreting χ2, P Value (mean, cm3) Mann-Whitney Test, P Value With 7 (1.79%) 25 (6.41%) 13.861, P < .001 49.84 ± 9.25 P = .972 23 (5.90%) 9 (2.31%) 18.937, P < .001 16.45 ± 22.18 Significant, P < .001 Without 201 (51.54%) 157 (40.26%) 45.61 ± 12.39 119 (30.51%) 239 (61.28%) 4.94 ± 6.18 Summary 208 (53.33%) 182 (46.67%) 45.78 ± 12.53 142 (36.41%) 248 (63.59%) 5.55 ± 7.43